Evaluating the results of treatments used in the management of Covid-19 patients
Keywords:
COVID-19 symptoms, Comorbidities, Treatment effect, Hospitalization time, and Mortality rate.Abstract
One of the most significant global health crises is the Coronavirus 2019
infection, which results from the SARS-Cov-2 virus. Objective: The purpose of this study is to evaluate the
clinical outcomes of COVID-19 treatments in Baghdad-Iraq hospitals. Patients and methods: Between the
8th of April 2022 and the 19th of October 2023, 120 patients who were documented as medical records of
SARS-CoV-2 were received at hospitals in Baghdad, Iraq. All demographic as well as clinical data for these
patients, including laboratory examinations, were compiled and evaluated. Results: The age group of 41 to
50 years constituted 45% of the total number of patients. Males were found to have the highest rate, with 72
cases compared to 48 cases in females. The most prevalent diseases among the patients were hypertension
(60 cases), diabetes (45 cases), chronic respiratory disease (35 cases), and cardiovascular disease (28 cases).
